1
|
Selvarajah A, Tavenier AH, Bor WL, Houben V, Rasoul S, Kaplan E, Teeuwen K, Hofma SH, Lipsic E, Amoroso G, van Leeuwen MAH, Ten Berg JM, van 't Hof AWJ, Hermanides RS. Feasibility and safety of cangrelor in patients with suboptimal P2Y 12 inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry. EUROPEAN HEART JOURNAL OPEN 2021; 1:oeab028. [PMID: 35923807 PMCID: PMC9242080 DOI: 10.1093/ehjopen/oeab028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 09/15/2021] [Accepted: 10/13/2021] [Indexed: 01/01/2023]
Affiliation(s)
- Abi Selvarajah
- Department of Cardiology, Isala Hospital, Zwolle, The Netherlands
| | | | - Wilbert L Bor
- Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
| | - Vital Houben
- Department of Cardiology, Zuyderland Medical Center, Heerlen, The Netherlands
| | - Saman Rasoul
- Department of Cardiology, Zuyderland Medical Center, Heerlen, The Netherlands.,Department of Cardiology, MUMC+, Maastricht, the Netherlands
| | - Eliza Kaplan
- Department of Cardiology, Venlo VieCuri Medical Center, Venlo, The Netherlands
| | - Koen Teeuwen
- Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands
| | - Sjoerd H Hofma
- Department of Cardiology, Medical Center Leeuwarden, Leeuwarden, The Netherlands
| | - Erik Lipsic
- Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands
| | - Giovanni Amoroso
- Department of Cardiology, OLVG Hospital, Amsterdam, The Netherlands
| | | | - Jur M Ten Berg
- Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.,Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
| | - Arnoud W J van 't Hof
- Department of Cardiology, Isala Hospital, Zwolle, The Netherlands.,Department of Cardiology, Zuyderland Medical Center, Heerlen, The Netherlands.,Department of Cardiology, MUMC+, Maastricht, the Netherlands.,Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
| | | |
Collapse
|